Q32 Bio Inc.

NASDAQ: QTTB · Real-Time Price · USD
1.93
0.05 (2.66%)
At close: Aug 15, 2025, 1:21 PM

Q32 Bio Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
77.97M 39.27M 43.89M 32.25M
Short-Term Investments
n/a 43.39M 141.04M 47.49M
Long-Term Investments
2.6M n/a 25.81M 1.95M
Other Long-Term Assets
763K n/a -20.06M -1M
Receivables
555K n/a 1.06M 909K
Inventory
n/a n/a 1.75M 769K
Other Current Assets
396K 1.26M 146K 73K
Total Current Assets
81.88M 83.91M 46.85M 34M
Property-Plant & Equipment
7.09M 650K 9.17M 203K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
10.46M 222.21M 14.92M 1.15M
Total Assets
92.33M 306.12M 61.77M 35.15M
Account Payables
2.99M 3.23M 1.44M 2.68M
Deferred Revenue
n/a n/a 14.53M 3.21M
Short-Term Debt
3.1M 1.32M 32.4M n/a
Other Current Liabilities
5.68M 1.27M 2.79M 1.49M
Total Current Liabilities
16.46M 11.57M 57.87M 7.22M
Long-Term Debt
9.56M n/a 5.07M 4.97M
Other Long-Term Liabilities
55M n/a 111.44M 112.17M
Total Long-Term Liabilities
70.19M 221.56M 134.62M 117.14M
Total Liabilities
86.66M 233.13M 192.49M 124.36M
Total Debt
18.9M 50.84M 44.73M 4.97M
Common Stock
2K 1K 1K 1K
Retained Earnings
-234.81M -542.1M -133.34M -90.53M
Comprehensive Income
n/a -5K -404K -7K
Shareholders Equity
5.67M 72.99M -130.71M -89.21M
Total Investments
2.6M 43.39M 166.85M 49.44M